Table of Contents
Diagnostic and Therapeutic Endoscopy
Volume 2, Issue 4, Pages 203-206

Photodynamic Therapy of Lung Cancer With Bronchial Artery Infusion of Photofrin

Department of Surgery, Tokyo Medical College, 6-7-1, Nishishinjuku, Shinjuku-ku, Tokyo 160, Japan

Received 15 March 1995; Accepted 25 December 1995

Copyright © 1996 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Photodynamic therapy (PDT) utilizing Photofrin is proving to be effective for the treatment of early stage lung cancer. However, wider clinical applications of Photofrin as a photosensitizer for various cancers are hampered by potentially serious and prolonged skin photosensitivity. To prevent these side effects and reduce the hospitalization period, we recently gave reduced doses of Photofrin by bronchial arterial infusion. Five patients with endoscopically evaluated minimally invasive carcinoma of the lung were given 0.7 mg/kg of Photofrin by bronchial arterial infusion 48 hr before PDT. Complete remission was obtained in all 5 cases and no case showed skin photosensitivity when exposed to sunlight under careful surveillance at one week after PDT.